Newsroom

Sorted by: Latest

-

Riassunto: Vonage amplia l'ecosistema degli sviluppatori per accelerare la prossima era della trasformazione digitale aziendale

HOLMDEL, N.J.--(BUSINESS WIRE)--Vonage, parte di Ericsson (NASDAQ: ERIC), oggi ha annunciato una serie di nuove iniziative per ampliare ulteriormente e potenziare la sua comunità globale di sviluppatori. Facendo crescere la sua comunità di sviluppatori e i loro strumenti, dando agli sviluppatori e alle aziende accesso a nuovi approfondimenti e funzionalità della rete mobile integrabili nelle applicazioni e nei flussi di lavoro esistenti, Vonage accelera la sua strategia per trasformare le reti...
-

Andersen Consulting udvider sine kompetencer inden for data og analyse med Insight Consulting

SAN FRANCISCO--(BUSINESS WIRE)--Andersen Consulting styrker sin platform gennem en samarbejdsaftale med Insight Consulting, der er en førende rådgivningsvirksomhed inden for data og digital strategi med tilstedeværelse i Sydafrika, Mozambique og Storbritannien. Insight Consulting tilbyder end-to-end-ydelser på tværs af den digitale værdikæde, herunder digital strategi, digital kompetenceudvikling, enterprise AI, skræddersyet softwareudvikling, dataintegration, analyse samt planlægning og foreca...
-

Vonage erweitert sein Entwickler-Ökosystem, um die nächste Ära der digitalen Unternehmenstransformation voranzutreiben

HOLMDEL, New Jersey--(BUSINESS WIRE)--Das zu Ericsson (NASDAQ: ERIC) gehörende Unternehmen Vonage hat heute eine Reihe neuer Initiativen angekündigt, mit denen es seine globale Entwickler-Community weiter ausbauen und stärken will. Durch die Erweiterung seiner Entwickler-Community und seiner Tools, die Entwicklern und Unternehmen Zugang zu neuen Erkenntnissen und Funktionen im Bereich Mobilfunknetze bieten, die in bestehende Anwendungen und Workflows integriert werden können, treibt Vonage sein...
-

Master Plan Communications Launches Material Handling Marketing Insights Video Series: “Handle More Business”

IRVING, Texas & RANCHO SANTA MARGARITA, Calif.--(BUSINESS WIRE)--MPC announces its “Handle More Business” video series released on the third Thursday of every month...
-

ESS Appoints Randall Selesky as Chief Commercial Officer to Accelerate Global Growth

WILSONVILLE, Ore.--(BUSINESS WIRE)--ESS Appoints Randall Selesky as Chief Commercial Officer to Accelerate Global Growth...
-

I/O Fund Proves Leadership in AI Stocks with 326% Cumulative Return and 29.2% Annualized Return

BOULDER, Colo.--(BUSINESS WIRE)--The I/O Fund has achieved a 326% cumulative return since its May 2020 debut, representing a 4.26x multiple. The team’s 29.2% annualized return has outpaced both broad market indexes and institutional tech-focused funds. In another year of strong relative outperformance, the I/O Fund achieved a 37% portfolio return in 2025. When excluding cryptocurrency, the team’s equity strategy delivered a staggering 56% return, a result that ranks the I/O Fund team among the...
-

Vonage élargit son écosystème de développeurs pour accélérer la prochaine ère de transformation numérique des entreprises

HOLMDEL, New Jersey--(BUSINESS WIRE)--Vonage, filiale d’Ericsson (NASDAQ : ERIC), a annoncé aujourd’hui plusieurs nouvelles initiatives visant à élargir et à renforcer sa communauté mondiale de développeurs. En développant sa communauté de développeurs et ses outils, en donnant aux développeurs et aux entreprises accès à de nouvelles informations et fonctionnalités sur les réseaux mobiles pouvant être intégrées dans les applications et les flux de travail existants, Vonage accélère sa stratégie...
-

NexEos Bio Announces FDA Clearance of IND Application to Proceed to Phase II/III Trial of NTX-1024 in Vernal Keratoconjunctivitis

MALVERN, Pa.--(BUSINESS WIRE)--NexEos Bio Vision Health (“NexEos”), a clinical-stage biopharmaceutical company developing novel therapies and diagnostics targeting eosinophil-mediated diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared NexEos’s Investigational New Drug (IND) Application to proceed to a Phase II/III clinical trial of NTX-1024 for the treatment of patients with the rare disease, vernal keratoconjunctivitis (VKC). The planned Phase II/III trial i...
-

New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer

SAN ANTONIO, Texas--(BUSINESS WIRE)--In new case study, CyPath Lung spares elderly woman from an invasive procedure for a suspicious lung nodule discovered on a CT scan....
-

Keysight Introduces Infiniium XR8 Oscilloscopes to Accelerate High-Speed Digital Validation and Compliance

SANTA ROSA, Calif.--(BUSINESS WIRE)--Next-generation architecture delivers faster analysis, clearer insights, and a compact design to turn days of digital validation into hours....